retatrutide type 2 diabetes phase 2 results 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 trial shows. is part of an emerging generation Lilly's triple agonist achieves 16.8%

Discuss with your healthcare team whether adjustment of other diabetes medications is needed

The difference in fat loss between the 8 mg and 12 mg weekly dose groups was approximately 1 percent

The most common side effects are digestive, such as nausea, bloating, or a change in bowel habits

GLP-1 Receptor Agonists (GLP-1RAs) Mechanism: Mimic GLP-1 via direct receptor stimulation at supraphysiological levels

Polyethylene glycol-modified ultra-small silicon nanoparticles (C dots) for tumor imaging can bind and enrich iron ions, which can be endocytosed into cells and lead to an increase in intracellular iron content, causing iron metabolism disorders in tumor cells (267, 268)

Targeting the gastrointestinal tract to treat type 2 diabetes